Heart–lung-on-a-chip featuring dynamic flow-resistance capture for drug-associated cardiac dysfunction assessment under tumor–immune-conditioned drug exposure

An integrated heart–lung LabChip reveals immune-mediated cardiotoxicity, featuring dynamic flow-resistance-enhanced trapping of heart organoids and tumor–T-cell co-culture to distinguish cardiotoxic effects of three anticancer drugs.